Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

Posters presented at the American Heart Association Scientific Sessions included results that show how persistent disparities ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

Robert F. Kennedy Jr, a prominent antivaccine activist and former independent presidential candidate, has been nominated to ...

Feedback, defined as data for primary care professionals on specific quality metrics, provides an opportunity for clinical staff to track aspects of their care that can be enhanced. Studies have ...

In the hours after President-elect Donald J. Trump tapped Robert F. Kennedy Jr to lead HHS, reactions came swiftly to the controversial pick who would have a large influence to shake up public health.

The combination therapy of bictegravir/emtricitabine/tenofovir (BIC/FTC/TAF) was both tolerable and produced virologic ...

The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

Male sex was also shown to be an independent risk factor for longer hospital stays and increased hospitalization costs at ...

A delay in the FDA decision for NT-501 could leave those with macular telangiectasia (MacTel) without any form of treatment ...

New study findings reveal that the risk of cardiovascular disease among light ex-smokers aligns quickly with never-smokers, ...

Clinical development and trial testing of vesleteplirsen (SRP-5051) for Duchenne muscular dystrophy (DMD) was stopped, with ...